Determinants of reservoir contraction and expansion in vivo, ex vivo, and in vitro
体内、离体和体外储库收缩和扩张的决定因素
基本信息
- 批准号:10022993
- 负责人:
- 金额:$ 55.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-16 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AcuteAffectAntigensAntisense RNAAntiviral AgentsAntiviral TherapyBar CodesCD4 Positive T LymphocytesCD8B1 geneCategoriesCell Cycle ArrestCell DeathCell divisionCellsCessation of lifeChronicClonal ExpansionDataExonsGene SilencingGenesGenetic TranscriptionGoalsHIVHIV InfectionsImmuneImmune TargetingImmune responseImmune systemIn VitroIndividualInfectionIntegration Host FactorsIntronsLeadLocationMeasuresMethodsMonitorMutateOncogenesOpen Reading FramesPlayProteinsProvirusesRNA SplicingResistanceRestRoleSample SizeSiteTestingTimeToxic effectTranscriptUntranslated RNAViralViremiaVirusWorkantiretroviral therapybasecohortcytotoxicitydeep sequencingdesigndriving forceexperimental studygenetic makeupimmune clearancein vitro Modelin vivointegration sitelatent HIV reservoirlongitudinal analysismutantpressurepromoterprotein expressiontranscriptome sequencing
项目摘要
The advent of antiviral therapy (ART) revealed a treatment-resistant reservoir in CD4+ T cells
capable of refueling HIV viremia when ART is stopped. This reservoir is a major barrier to
achieving a cure for HIV infection. Our recent work suggests the inherent reservoir decay is
more rapid than previously recognized. This decay is obscured due to an opposing force that
results in proviral clonal expansion. The driving forces behind proviral clonal expansion remain
mysterious, but integration into introns of oncogenes may play a role. Overall objective: In this
proposal, we dissect the drivers of reservoir contraction (Aim 1) and expansion (Aim 2). Our
approach will be to perturb both forces and to study the resulting effects. We will use proviral,
integration site, and RNA sequencing to understand how perturbing these forces affects the
genetic make-up of proviruses, their propensity to expand, and their expression. Our approach
is to perform massive deep sequencing in a few individuals rather than large sample size. We
believe our intriguing results validate our deliberate decision to limit sample size to obtain
deeper sequence information within each individual. With this approach, we recently provided
unprecedented depth and elucidated previously unknown selection pressures. Design and
Methods: In Aim 1, we isolate the role of immune clearance by measuring reservoir contraction
in vivo and in vitro. We also dissect the cytotoxicity induced by HIV proteins by mutating
individuals Open Reading Frames before infecting CD4 T cells with a barcoded virus. In Aim 2,
we dissect the drivers of clonal expansion, including HIV-driven cell division, by using a
barcoded virus. We also use longitudinal integration site analysis to compare the rate of clonal
expansion as well as the “character” of the expanded proviral clones in elite controllers, acutely
and chronically infected individuals on ART.
The premise of our proposal is largely based on our work showing that there are two
counterbalancing forces that cause (1) proviral contraction through viral cytotoxicity and immune
clearance and (2) proviral expansion through clonal proliferation. The significance of our
proposal includes that it may contribute to growing evidence that the reservoir is more visible
than previously realized. We envision this work could lead to approaches that enhance immune
clearance or target splicing to reduce reservoir size.
抗病毒疗法的冒险(ART)揭示了CD4+ T细胞中对治疗的储层
停止艺术时能够加毒艾滋病毒血症。该水库是
实现治愈艾滋病毒感染的方法。我们最近的工作表明,继承的储层衰减是
比以前认识的要快。由于对立的力量,这种衰变被遮挡了
导致前毒性克隆扩张。前病毒膨胀背后的驱动力仍然存在
神秘的,但整合到癌基因的内含子中可能起作用。总体目标:在此中
提案,我们剖析了储层收缩的驱动因素(AIM 1)和扩展(AIM 2)。我们的
方法将是扰动两种力并研究产生的效果。我们将使用前病毒,
集成位点和RNA测序以了解这些力如何影响这些力
病毒的基因组成,他们的诺言及其表达。我们的方法
是在几个个体而不是大型样本量中进行大量的深层测序。我们
相信我们有趣的结果可以验证我们故意限制样本量以获得的决定
每个人内的更深序列信息。通过这种方法,我们最近提供了
前所未有的深度和先前未知的选择压力。设计和
方法:在AIM 1中,我们通过测量储层收缩来构成免疫化的作用
体内和体外。我们还通过突变剖析了HIV蛋白诱导的细胞毒性
在AIM 2中,个体在用条形码病毒感染CD4 T细胞之前打开阅读框架。
我们通过使用A剖析克隆扩张的驱动因素,包括HIV驱动的细胞分裂
条形码病毒。我们还使用纵向整合位点分析来比较克隆的速率
扩展以及Elite Controller中扩展的提供商克隆的“角色”,敏锐地
以及长期感染艺术的人。
我们的提案的前提在很大程度上基于我们的工作表明有两个
通过病毒细胞毒性和免疫的临时收缩引起的平衡力(1)
清除率和(2)通过克隆增殖的病毒扩张。我们的意义
提案包括,它可能有助于越来越多的证据表明水库更可见
比以前意识到的。我们设想这项工作可能会导致增强免疫力
清除或目标剪接以减小储层尺寸。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Una T O'Doherty其他文献
Una T O'Doherty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Una T O'Doherty', 18)}}的其他基金
The barcode project: a strategy to track the early naïve reservoir
条形码项目:追踪早期幼稚水库的策略
- 批准号:
10762820 - 财政年份:2023
- 资助金额:
$ 55.65万 - 项目类别:
Determinants of reservoir contraction and expansion in vivo, ex vivo, and in vitro
体内、离体和体外储库收缩和扩张的决定因素
- 批准号:
10358573 - 财政年份:2020
- 资助金额:
$ 55.65万 - 项目类别:
Determinants of reservoir contraction and expansion in vivo, ex vivo, and in vitro
体内、离体和体外储库收缩和扩张的决定因素
- 批准号:
10579911 - 财政年份:2020
- 资助金额:
$ 55.65万 - 项目类别:
Unveiling the chromosomal address of intact HIV clones to provide insights into persistence
揭示完整 HIV 克隆的染色体地址,以提供对持久性的见解
- 批准号:
9790462 - 财政年份:2019
- 资助金额:
$ 55.65万 - 项目类别:
Unveiling the chromosomal address of intact HIV clones to provide insights into persistence
揭示完整 HIV 克隆的染色体地址,以提供对持久性的见解
- 批准号:
9889887 - 财政年份:2019
- 资助金额:
$ 55.65万 - 项目类别:
An ex vivo model to predict outcomes and probe mechanism of anti-reservoir agents
预测抗储库药物结果和探讨机制的离体模型
- 批准号:
8930064 - 财政年份:2014
- 资助金额:
$ 55.65万 - 项目类别:
An ex vivo model to predict outcomes and probe mechanism of anti-reservoir agents
预测抗储库药物结果和探讨机制的离体模型
- 批准号:
8842406 - 财政年份:2014
- 资助金额:
$ 55.65万 - 项目类别:
Probing mechanisms of reduced HIV reservoirs in an interferon-a clinical trial
干扰素临床试验中探索减少 HIV 储存的机制
- 批准号:
8603530 - 财政年份:2013
- 资助金额:
$ 55.65万 - 项目类别:
相似国自然基金
E3泛素连接酶MDM2对乙肝表面抗原组装和分泌的影响及机制研究
- 批准号:82300690
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
甲型流感病毒H1N1变异对抗原性和感染性的影响机制研究
- 批准号:82372225
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
幽门螺杆菌O-抗原连接酶WaaL通过调控IV型分泌系统的组装影响其致病性的机制研究
- 批准号:82300649
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Spike变异对新冠病毒抗原性及ACE2种属嗜性的影响研究
- 批准号:82272305
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
新型H5亚型禽流感病毒变异对抗原性影响及其分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 55.65万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 55.65万 - 项目类别:
Prognostic implications of mitochondrial inheritance in myelodysplastic syndromes after stem-cell transplantation
干细胞移植后骨髓增生异常综合征线粒体遗传的预后意义
- 批准号:
10662946 - 财政年份:2023
- 资助金额:
$ 55.65万 - 项目类别:
Temporospatial Single-Cell Characterization of Angiogenesis and Myocardial Regeneration in Small and Large Mammals
小型和大型哺乳动物血管生成和心肌再生的时空单细胞表征
- 批准号:
10751870 - 财政年份:2023
- 资助金额:
$ 55.65万 - 项目类别: